PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $21,448,000 | -3.7% | 315,183 | +39.9% | 0.23% | +7.9% |
| Q4 2017 | $22,264,000 | -55.1% | 225,232 | -45.6% | 0.22% | -48.7% |
| Q3 2017 | $49,578,000 | -6.3% | 414,010 | -31.6% | 0.42% | -26.7% |
| Q2 2017 | $52,908,000 | +84.5% | 605,360 | -21.5% | 0.57% | +92.0% |
| Q1 2017 | $28,681,000 | +514.2% | 771,000 | +1827.5% | 0.30% | +443.6% |
| Q2 2015 | $4,670,000 | +253.8% | 40,000 | +100.0% | 0.06% | +223.5% |
| Q2 2014 | $1,320,000 | -15.5% | 20,000 | +33.3% | 0.02% | -32.0% |
| Q1 2014 | $1,562,000 | -66.5% | 15,000 | -66.7% | 0.02% | -57.6% |
| Q4 2013 | $4,659,000 | +5.0% | 45,000 | -55.0% | 0.06% | -22.4% |
| Q2 2013 | $4,437,000 | – | 100,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |